Cancer Research AACR Membership  Metabolism
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Farhana, L.
Right arrow Articles by Fontana, J. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Farhana, L.
Right arrow Articles by Fontana, J. A.
[Cancer Research 65, 4909-4917, June 1, 2005]
© 2005 American Association for Cancer Research


Experimental Therapeutics, Molecular Targets, and Chemical Biology

Apoptosis Induction by a Novel Retinoid-Related Molecule Requires Nuclear Factor-{kappa}B Activation

Lulu Farhana1,2, Marcia I. Dawson3 and Joseph A. Fontana1,2

1 John D Dingell Veterans Affairs Medical Center; 2 Karmanos Cancer Institute and Department of Medicine, Wayne State University, Detroit, Michigan; and 3 The Burnham Institute, San Diego, California

Requests for reprints: Joseph A. Fontana, John D Dingell Veterans Affairs Medical Center, Oncology 11M-HO, Room C3687, 4646 John R. Street, Detroit, MI 48201. Phone: 313-576-3659; Fax: 313-576-1122; E-mail: joseph.fontana{at}med.va.gov.

Nuclear factor-{kappa}B (NF-{kappa}B) activation has been shown to be both antiapoptotic and proapoptotic depending on the stimulus and the specific cell type involved. NF-{kappa}B activation has also been shown to be essential for apoptosis induction by a number of agents. The novel retinoid-related molecule 4-[3-Cl-(1-adamantyl)-4-hydroxyphenyl]-3-chlorocinnamic acid (3-Cl-AHPC) activates NF-{kappa}B with subsequent apoptosis in a number of cell types. We have found that NF-{kappa}B activation is essential for 3-Cl-AHPC–mediated apoptosis. 3-Cl-AHPC activates NF-{kappa}B through IKK{alpha} kinase activation and the subsequent degradation of I{kappa}B{alpha}. IKK{alpha} kinase activation is associated with IKK{alpha}-enhanced binding to HSP90. The HSP90 inhibitor geldanamycin enhances the degradation of IKK{alpha} and blocks 3-Cl-AHPC activation of NF-{kappa}B and 3-Cl-AHPC–mediated apoptosis. In addition, inhibition of I{kappa}B{alpha} degradation using a dominant-negative I{kappa}B{alpha} inhibits 3-Cl-AHPC–mediated apoptosis. NF-{kappa}B p65 activation is essential for 3-Cl-AHPC apoptosis induction as evidenced by the fact that inhibition of p65 activation utilizing the inhibitor helenalin or loss of p65 expression block 3-Cl-AHPC–mediated apoptosis. NF-{kappa}B has been shown to be antiapoptotic through its enhanced expression of a number of antiapoptotic proteins including X-linked inhibitor of apoptosis protein (XIAP), c-IAP1, and Bcl-XL. Whereas exposure to 3-Cl-AHPC results in NF-{kappa}B activation, it inhibits the expression of XIAP, c-IAP1, and Bcl-XL and enhances the expression of proapoptotic molecules, including the death receptors DR4 and DR5 as well as Fas and Rip1. Thus, 3-Cl-AHPC, which is under preclinical development, has pleotrophic effects on malignant cells resulting in their apoptosis.




This article has been cited by other articles:


Home page
Molecular Cancer TherapeuticsHome page
L. Farhana, M. I. Dawson, L. Xu, and J. A. Fontana
SHP and Sin3A expression are essential for adamantyl-substituted retinoid-related molecule-mediated nuclear factor-{kappa}B activation, c-Fos/c-Jun expression, and cellular apoptosis
Mol. Cancer Ther., June 1, 2009; 8(6): 1625 - 1635.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
L. Zhu, C. Johnson, and M. Bakovic
Stimulation of the human CTP:phosphoethanolamine cytidylyltransferase gene by early growth response protein 1
J. Lipid Res., October 1, 2008; 49(10): 2197 - 2211.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
C. Valli, G. Paroni, A. M. Di Francesco, R. Riccardi, M. Tavecchio, E. Erba, A. Boldetti, M. Gianni', M. Fratelli, C. Pisano, et al.
Atypical retinoids ST1926 and CD437 are S-phase-specific agents causing DNA double-strand breaks: significance for the cytotoxic and antiproliferative activity
Mol. Cancer Ther., September 1, 2008; 7(9): 2941 - 2954.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
S. H. Lee, S. M. Son, D. J. Son, S. M. Kim, T. J. Kim, S. Song, D. C. Moon, H. W. Lee, J. C. Ryu, D.-Y. Yoon, et al.
Epothilones induce human colon cancer SW620 cell apoptosis via the tubulin polymerization independent activation of the nuclear factor-{kappa}B/I{kappa}B kinase signal pathway
Mol. Cancer Ther., October 1, 2007; 6(10): 2786 - 2797.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
S.-H. Kim, C.-I. Hwang, Y.-S. Juhnn, J.-H. Lee, W.-Y. Park, and Y.-S. Song
GADD153 mediates celecoxib-induced apoptosis in cervical cancer cells
Carcinogenesis, January 1, 2007; 28(1): 223 - 231.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
S.-H. Kim, C.-I. Hwang, W.-Y. Park, J.-H. Lee, and Y.-S. Song
GADD153 mediates celecoxib-induced apoptosis in cervical cancer cells
Carcinogenesis, October 1, 2006; 27(10): 1961 - 1969.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
X. Dolcet, D. Llobet, M. Encinas, J. Pallares, A. Cabero, J. A. Schoenenberger, J. X. Comella, and X. Matias-Guiu
Proteasome Inhibitors Induce Death but Activate NF-{kappa}B on Endometrial Carcinoma Cell Lines and Primary Culture Explants
J. Biol. Chem., August 4, 2006; 281(31): 22118 - 22130.
[Abstract] [Full Text] [PDF]


Home page
MicrobiologyHome page
S. Brozovic, R. Sahoo, S. Barve, H. Shiba, S. Uriarte, R. S. Blumberg, and D. F. Kinane
Porphyromonas gingivalis enhances FasL expression via up-regulation of NF{kappa}B-mediated gene transcription and induces apoptotic cell death in human gingival epithelial cells.
Microbiology, March 1, 2006; 152(Pt 3): 797 - 806.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2005 by the American Association for Cancer Research.